Concentra Operating Income from 2010 to 2026
| CON Stock | 23.86 0.72 3.11% |
Operating Income | First Reported 2010-12-31 | Previous Quarter 350.5 M | Current Value 308.2 M | Quarterly Volatility 22.4 M |
Check Concentra Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Concentra Group's main balance sheet or income statement drivers, such as Tax Provision of 42.4 M, Depreciation And Amortization of 59.2 M or Interest Expense of 68 M, as well as many indicators such as Price To Sales Ratio of 1.69, Dividend Yield of 0.0121 or PTB Ratio of 8.69. Concentra financial statements analysis is a perfect complement when working with Concentra Group Valuation or Volatility modules.
Concentra | Operating Income | Build AI portfolio with Concentra Stock |
Evaluating Concentra Group's Operating Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Concentra Group Holdings's fundamental strength.
Latest Concentra Group's Operating Income Growth Pattern
Below is the plot of the Operating Income of Concentra Group Holdings over the last few years. Operating Income is the amount of profit realized from Concentra Group Holdings operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Concentra Group Holdings is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Concentra Group's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Concentra Group's overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
Concentra Operating Income Regression Statistics
| Arithmetic Mean | 279,559,449 | |
| Geometric Mean | 278,793,792 | |
| Coefficient Of Variation | 8.02 | |
| Mean Deviation | 15,632,451 | |
| Median | 270,265,000 | |
| Standard Deviation | 22,422,827 | |
| Sample Variance | 502.8T | |
| Range | 92.3M | |
| R-Value | 0.61 | |
| Mean Square Error | 334.6T | |
| R-Squared | 0.38 | |
| Significance | 0.01 | |
| Slope | 2,722,862 | |
| Total Sum of Squares | 8044.5T |
Concentra Operating Income History
About Concentra Group Financial Statements
Concentra Group investors utilize fundamental indicators, such as Operating Income, to predict how Concentra Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Income | 350.5 M | 308.2 M |
Pair Trading with Concentra Group
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Concentra Group position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Concentra Group will appreciate offsetting losses from the drop in the long position's value.Moving together with Concentra Stock
Moving against Concentra Stock
| 0.66 | REG | Regis Healthcare | PairCorr |
| 0.58 | UNH | UnitedHealth Group CDR | PairCorr |
| 0.57 | HUM | Humana Inc Earnings Call Today | PairCorr |
| 0.55 | UNH | UnitedHealth Group | PairCorr |
| 0.53 | UHS | Universal Health Services | PairCorr |
The ability to find closely correlated positions to Concentra Group could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Concentra Group when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Concentra Group - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Concentra Group Holdings to buy it.
The correlation of Concentra Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Concentra Group moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Concentra Group Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Concentra Group can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Concentra Group Correlation against competitors. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Will Health Care Providers & Services sector continue expanding? Could Concentra diversify its offerings? Factors like these will boost the valuation of Concentra Group. Projected growth potential of Concentra fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Concentra Group data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.026 | Dividend Share 0.25 | Earnings Share 1.17 | Revenue Per Share | Quarterly Revenue Growth 0.17 |
Investors evaluate Concentra Group Holdings using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Concentra Group's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Concentra Group's market price to deviate significantly from intrinsic value.
It's important to distinguish between Concentra Group's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Concentra Group should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Concentra Group's market price signifies the transaction level at which participants voluntarily complete trades.